Wedbush Securities Inc Aspira Women'S Health Inc. Transaction History

Wedbush Securities Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$0.4 - $1.09 $18,954 - $51,649	-47,385 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$0.88 - $1.81 $13,816 - $28,417	-15,700 Reduced 24.89%	47,385 $49,000
Q4 2021 Jan 13, 2022	SELL	$1.63 - $3.43 $31,320 - $65,907	-19,215 Reduced 23.35%	63,085 $111,000
Q3 2021 Oct 08, 2021	SELL	$3.19 - $5.48 $8,613 - $14,796	-2,700 Reduced 3.18%	82,300 $267,000
Q2 2021 Jul 27, 2021	SELL	$4.78 - $6.84 $66,920 - $95,760	-14,000 Reduced 14.14%	85,000 $477,000
Q1 2021 Apr 26, 2021	SELL	$5.9 - $9.13 $34,220 - $52,954	-5,800 Reduced 5.53%	99,000 $668,000
Q4 2020 Feb 16, 2021	SELL	$3.0 - $6.71 $51,615 - $115,445	-17,205 Reduced 14.1%	104,800 $703,000
Q3 2020 Oct 20, 2020	BUY	$2.54 - $4.56 $309,892 - $556,342	122,005 New	122,005 $376,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.